Media Resources

16 April

Comprendre la promotion pharmaceutique et y répondre: Un manuel pratique

9 April

EU-India free trade deal puts millions of lives at risk

1 March

2012 Annual Report

1 March

2012 Financial Statements

16 July

ACTA is dead, long live ACTA? ACTA-like measures still in EU IP policies

8 June

Time for the final push: Say “No” to ACTA – again

15 May

EU Parliament Says No and No Again to EMA: Independent Groups Echo Decision

28 March

Big Pharma Spends Over €40 Million per Year Lobbying in the EU, Dwarfing Public Health NGOs

26 March

Civil Society Calls on Members of the European Parliament to Condemn ACTA

20 March

Divide and Conquer: A look behind the scenes of the EU pharmaceutical industry lobby

10 January

Business Conduct Guidelines

10 January

Complaints Procedure (EN)

1 January

Unlocking the Mysteries of Access to Clinical Trials Data in the EU

14 October

Statement on Medicines Patent Pool

1 September

Universal Access to Medicines for Non-Communicable Diseases

8 July

Drop in Pay-for-Delay Good for Access to Medicines in Europe

20 May

Statement on Conflicts of Interests delivered at WHA

18 March

Statement on EU India and EU Mercosur Free-Trade Negotiations

21 January

Medicines pay-for-delay back under the microscope

30 September

EU Citizens Get a Voice in Pharmacovigilance

1 July

Understanding & Responding to Pharmaceutical Promotion: A Practical Guide

22 November

Unbiased medicines’ information: European best practices

1 November

Wyzwanie dla niezależnej informacji: dyrektywa w sprawie informowania pacjentów

1 October

Understanding and Responding to Pharmaceutical Promotion: A Practical Guide

11 August

The Tide is Turning Against Pharmaceutical Ads

11 August

Protect Legitimate Trade in Essential Medicines

3 April

HAI Requests Government Documents on Generic Medicines Seizures

20 March

Release of Generic ARV Medicines by Dutch Customs Authorities

27 July

HAI Constitution

7 October

Fast, Furious, and Flexible